Alterity Therapeutics Limited
ATHE | NASDAQ
$3.83
+$0.05 (+1.32%)
Sep 22, 2026, 2:17 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 29, 2026 | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 37.32M | 33.16M | 12.64M | 15.77M | 34.81M | 28.12M |
Short-Term Investments | n/a | 7.5M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 7.7M | 3.94M | 4.04M | 8.65M | 4.67M | 4.13M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 42.8K | 41.82K | 40.67K | 56.6K | 66.19K | 160.67K |
Total Current Assets | 45.83M | 45.87M | 19.04M | 27.05M | 41.14M | 33.49M |
Property-Plant & Equipment | 190.57K | 155.17K | 186.88K | 268.86K | 218.52K | 96.81K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 190.57K | 155.17K | 186.88K | 268.86K | 218.52K | 96.81K |
Total Assets | 46.02M | 46.03M | 19.22M | 27.32M | 41.36M | 33.59M |
Account Payables | 1.12M | 538.28K | 581.14K | 1.72M | 2.64M | 1.45M |
Deferred Revenue | n/a | n/a | n/a | -107.18K | -57.63K | n/a |
Short-Term Debt | 55.18K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 891.45K | 876.05K | 4.12M | 169.02K | 2.5M | 33.85K |
Total Current Liabilities | 3.16M | 3.53M | 5.37M | 4.38M | 5.82M | 3.07M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 19.5K | 13.75K | 9.77K |
Total Long-Term Liabilities | 138.3K | 88.55K | 51.91K | 122.71K | 73.61K | 47.67K |
Total Liabilities | 3.29M | 3.62M | 5.43M | 4.5M | 5.89M | 3.12M |
Total Debt | 193.48K | 155.46K | 159.05K | 210.38K | 117.49K | 65.65K |
Book Value | 42.73M | 42.4M | 13.8M | 22.81M | 35.47M | 30.47M |
Book Value Per Share | 2.44 | 3.98 | 2.27 | 5.64 | 8.85 | 10.77 |
Common Stock | 282.53M | 262.95M | 223.15M | 213.97M | 213.79M | 197.45M |
Retained Earnings | -245.6M | -225.89M | -214.16M | -195.13M | -181.88M | -169.73M |
Comprehensive Income | 5.8M | 5.34M | 4.81M | 3.97M | 3.57M | 2.75M |
Shareholders Equity | 42.73M | 42.4M | 13.8M | 22.81M | 35.47M | 30.47M |
Total Investments | n/a | 7.5M | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ATHE